Quantcast

Latest asthma Stories

2014-09-19 08:26:05

DALLAS, September 19, 2014 /PRNewswire/ -- RnRMarketResearch.com adds asthma drugs market research reports titled "Asthma - Japan Drug Forecast and Market Analysis to 2023", "Asthma - US Drug Forecast and Market Analysis to 2023" and "Asthma - 5EU Drug Forecast and Market Analysis to 2023" to its online library. According to Asthma - 5EU Drug Forecast and Market Analysis to 2023...

2014-09-17 23:07:08

DeepResearchReports.com adds “2014 Market Research Report on Global and China DEHP Plasticizer Industry” and “2014 Market Research Report on Global SiC Substrates Industry” to its research database. Dallas, Texas (PRWEB) September 17, 2014 2014 Market Research Report on Global DEHP Plasticizer Industry” is a professional and in-depth research report on the China DEHP Plasticizer market. The report provides basic DEHP Plasticizer information, including its definition,...

2014-09-17 23:02:58

Rare Virus Has Been Reported in 12 States, May Be Coming to Texas FRISCO, Texas (PRWEB) September 17, 2014 Prevention is the best treatment for the Enterovirus D68 (EV-D68) outbreak that is hospitalizing scores of infants, children and teenagers in 12 states, including nearby Oklahoma and Louisiana, says Dr. Kirk Mahon, medical director of Legacy ER & Urgent Care (LER) in Frisco, Texas. “There have been no reported cases of EV-D68 so far in North Texas, but with it hitting Oklahoma...

2014-09-15 20:21:53

MarketOptimizer.org adds new report "EpiCast Report: Asthma - Epidemiology Forecast to 2023" to its store. In 2013, there were 137.66 million lifetime prevalent cases of asthma in the 10MM, with 82.71 million cases in the US (43.16 million cases) and India (39.55 million cases) combined. DALLAS, Sept. 15, 2014 /PRNewswire-iReach/ -- Asthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term condition...

2014-09-12 04:20:43

LONDON, September 12, 2014 /PRNewswire/ -- Kind Consumer today announced that it has received a product licence for the Company's proprietary nicotine inhaler (Voke Inhaler 0.45mg) for General Sale from the UK Medicines and Healthcare products Regulatory Agency (MHRA). This is a key milestone in the journey towards bringing this important innovation to consumers. The next step will be to submit a variation to the licence to support full-scale commercialisation by our...

2014-09-11 08:27:34

SALT LAKE CITY, Sept. 11, 2014 /PRNewswire-USNewswire/ -- Arches Health Plan announced today that it has partnered with Symptomly to provide a more integrated care strategy to asthmatic members. In the United States there are currently over 25 million Asthmatics, or 1 in every 12 people is suffering from Asthma. Of those, 2.1 million will be admitted to a hospital or emergency room this year. The estimated medical costs for asthmatics patients can be as high as $60 million dollars...

2014-09-11 04:21:18

OXFORD, England, September 11, 2014 /PRNewswire/ -- Successful Completion of Biomedical Catalyst Programme Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle(TM) (MCP(TM)) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases. The Company...

Schools Without Health Plans Unprepared To Handle Life-threatening Emergencies
2014-09-10 03:15:17

By Marla Paul, Northwestern University Only one in four students with asthma and half of children with food allergies have emergency health management plans in place at school, leaving schools inadequately prepared to manage daily needs and handle medical emergencies related to often life-threatening medical conditions, reports a new Northwestern Medicine study in partnership with Chicago Public Schools (CPS). "Given the amount of time kids spend in school, it's critical for school...

2014-09-08 12:29:32

For U.S. Media Only RIDGEFIELD, Conn., Sept. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented new data from the company's Phase III trial program (UniTinA-asthma(®)) evaluating tiotropium in asthma, including the first study assessing the efficacy and safety of tiotropium in adolescent patients with symptomatic asthma. These data were unveiled during an oral session at the European Respiratory Society (ERS) International Congress 2014 in Munich, Germany. Tiotropium is...

infant sleeping on fur
2014-09-08 04:00:44

Lauren Anderson, European Lung Foundation Sleeping on animal fur in the first three months of life might reduce the risk of asthma in later childhood a new study has found. The new research, presented at the European Respiratory Society (ERS) International Congress in Munich on September 8, 2014, suggests that exposure to the microbial environment in animal skin and fur could have a protective effect against asthma and allergies. Previous studies have suggested that exposure to a...


Latest asthma Reference Libraries

Journal of Allergy and Clinical Immunology
2012-05-14 11:51:18

The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...

More Articles (1 articles) »
Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related